| Description | PCSK9-IN-19 (Compound 1), a PCSK9 inhibitor, is utilized in researching the treatment of high LDL-cholesterol levels and the prevention of coronary artery disease [1]. |
| molecular weight | 1647.37 |
| Molecular formula | C81H105ClFN15O15S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |